99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer

Clinical trial NCT04233476 · COMPLETED

Trial details

NCT number: NCT04233476
Sponsor: RDO Pharm.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer Lymph Node Metastasis

Start date: 2019-10-12
Primary completion: 2021-05-08
Enrollment: 409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.